| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6199327 | Ophthalmology | 2015 | 6 Pages |
Abstract
AR-13324 0.02% was less effective than latanoprost by approximately 1 mmHg in patients with unmedicated IOPs of 22 to 35 mmHg. The major safety finding was ocular hyperemia, which was more common for both concentrations of AR-13324 than for latanoprost.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Jason MD, Harvey B. MD, Brian OD, MS, Casey C. PhD, Gary D. PhD, AR-13324-CS202 Study Group AR-13324-CS202 Study Group,